Paul-Gunther Sator

Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial

Andrea Vaclavkova, Sergio Chimenti, Petr Arenberger et al. · The Lancet · 2014 · 148 citations

Dentistry, Pharmacotherapy, Oral Medicine In Older Adults +5

Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis*

Thomas Graier, Wolfgang Salmhofer, Constanze Jonak et al. · British Journal of Dermatology · 2020 · 64 citations · Full text

Medicine, Immunology, Pharmacotherapy +14

Evaluation of Low-Dose, Low-Frequency Oral Psoralen–UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides

Pablo Vieyra-Garcia, Regina Fink‐Puches, Stefanie Porkert et al. · JAMA Dermatology · 2019 · 51 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Response of vitiligo to once‐ vs. twice‐daily topical tacrolimus: a controlled prospective, randomized, observer‐blinded trial

Sonja Radaković, J. Breier-Maly, Reinhard Konschitzky et al. · Journal of the European Academy of Dermatology and Venereology · 2009 · 45 citations

Life Sciences, Dermatology, Ophthalmology +10

Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study

Uta Kiltz, Petros P. Sfikakis, Karl Gaffney et al. · Advances in Therapy · 2020 · 39 citations · Full text

Medicine, Immunology, Pharmacotherapy +17